Weiguo Qing
Corporate Officer/Principal at Hutchison MediPharma Ltd.
Weiguo Qing active positions
| Companies | Position | Start | End |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 2007-12-31 | - |
Career history of Weiguo Qing
Former positions of Weiguo Qing
| Companies | Position | Start | End |
|---|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
| Roche Corp. | Corporate Officer/Principal | - | - |
Training of Weiguo Qing
| The University of Texas at Austin | Doctorate Degree |
| Institute of Materia Medica | Graduate Degree |
Statistics
International
| United States | 4 |
| China | 3 |
Operational
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private companies | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Roche Corp. |
- Stock Market
- Insiders
- Weiguo Qing
- Experience
